Open Medicines for Europe letter ahead of the Energy Council – 27 September 2022

27 September 2022

EMA/HMA share definitive EU-wide position on biosimilar medicines interchangeability

19 September 2022

Medicines for Europe is part of the REMEDi4ALL consortium! An EU-funded research initiative aiming at driving forward the repurposing of medicines in Europe

2 September 2022

REMEDi4ALL launched yesterday with the aim of making a major […]

Medicines for Europe warns strongly against energy rationing for medicines production

20 July 2022

The Supplementary Protection Certificate (SPC) manufacturing waiver becomes operational!

1 July 2022

The off-patent medicines industry is a vital part of the solution for healthcare resilience

30 June 2022

Smart reform of EU pharma and IP legislation key to boosting access to essential medicines

28 June 2022

EPSCO (Health) Council – Open letter from Medicines for Europe Executive Committee to European Health Ministers and responsible European Commissioners on inflation impacting the supply of essential medicines

9 June 2022

Pharmaboardroom – An EU Pharma Policy Framework for Better Access to Affordable Medicines

17 May 2022

Open

EU can do more for patients with smart use of biosimilar medicines

28 April 2022